Evidence map›Paper›PMID 29649141›Full record

ArticleMarine drugs2018

Anticancer Activity of Anthopleura anjunae Oligopeptides in Prostate Cancer DU-145 Cells.

Zong-Ze Wu, Guo-Fang Ding, Fang-Fang Huang, Zui-Su Yang, Fang-Miao Yu, Yu-Ping Tang, Ying-Lu Jia, Yuan-Yuan Zheng, Rui Chen

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Antitumor potential of ivermectin against T-cell lymphoma-bearing hosts.Medical oncology (Northwood, London, England) · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Serine Protease fromMarine drugs · 2019
    Article
  17. A Novel Peptide from Abalone (Marine drugs · 2019
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zong-Ze WuSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. zongze461@sina.com.
Guo-Fang DingSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. dinggf@zjou.edu.cn.
Fang-Fang HuangSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. dingguofang2007@126.com.
Zui-Su YangSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. abc1967@126.com.
Fang-Miao YuSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. ymyu@zjou.edu.cn.
Yu-Ping TangSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. tangyunping1985@163.com.ORCID 0000-0002-4450-2956
Ying-Lu JiaSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. m18768013696@163.com.
Yuan-Yuan ZhengSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. zhengxiaohuo1990@163.com.
Rui ChenSchool of Food Science and Pharmacy of Zhejiang Ocean University, Zhejiang Provincial Key Engineering Technology Research Center of Biomedical Products, Zhoushan 316022, China. 15595676203@163.com.
Zhejiang Ocean University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnnexin A5Antineoplastic AgentsApoptosisbcl-2-Associated X ProteinCaspase 3Caspase 9CaspasesCell Line, TumorCell ProliferationCytochromes cHumansMaleMembrane Potential, MitochondrialMitochondriaOligopeptidesAnnexin A5Antineoplastic Agentsbcl-2-Associated X ProteinCaspase 3Caspase 9CaspasesCytochromes cOligopeptidesProlineprolyl-glycyl-prolineProto-Oncogene Proteins c-bcl-2Anthopleura anjunaeapoptosis-associated proteinsapoptosis ratemitochondria membrane potentialmorphology

Identifiers

PMID29649141
PMCPMC5923412
OpenAlexW2797597830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.